Cart
sales@molnova.com
Beta-Tocopherol
CAS No. 148-03-8
Beta-Tocopherol( —— )
Catalog No. M29104 CAS No. 148-03-8
Beta-Tocopherol shows effect on human erythroleukemia cell (HEL) adhesion induced by phorbol 12-myristate 13-acetate (PMA).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 71 | Get Quote |
|
| 5MG | 115 | Get Quote |
|
| 10MG | 191 | Get Quote |
|
| 25MG | 323 | Get Quote |
|
| 50MG | 482 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBeta-Tocopherol
-
NoteResearch use only, not for human use.
-
Brief DescriptionBeta-Tocopherol shows effect on human erythroleukemia cell (HEL) adhesion induced by phorbol 12-myristate 13-acetate (PMA).
-
DescriptionBeta-Tocopherol shows effect on human erythroleukemia cell (HEL) adhesion induced by phorbol 12-myristate 13-acetate (PMA).(In Vitro):Adhesion induced by PMA stimulation was prevented by 44.5% by physiological concentrations of alpha-tocopherol. Under the same experimental conditions, beta-tocopherol, an analogue of alpha-tocopherol, produced 11% inhibition of adhesion. Cell response gradually increased from 0 to 24 h of alpha-tocopherol treatment. Only a slight time dependency of beta-tocopherol inhibition was observed. Another human erythroleukemia cell line (K562) and the human monocyte tumor cell line U937 showed 5.0 and 11.2% inhibition, respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetPERK
-
RecptorERK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number148-03-8
-
Formula Weight416.7
-
Molecular FormulaC28H48O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@](C)(CC1)Oc(c(C)c2)c1c(C)c2O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Epieriocalyxin A
Epieriocalyxin A can suppress Caco-2 colon cancer cell growth. It could be a potential drug for colon cancer therapy in the future.
-
BTdCPU
BTdCPU is a potent heme-regulated eIF2α kinase (HRI) activator.?BTdCPU promotes eIF2α phosphorylation and induced apoptosis in resistant cell.
-
DNL343
DNL343 is a selective and potent eIF2B activator that crosses the blood-brain barrier and inhibits the assembly of stress granules (SGs) induced by the C9ORF72 dipeptide repeats.
